Atomistry » Bromine » PDB 4alv-4d46 » 4bae
Atomistry »
  Bromine »
    PDB 4alv-4d46 »
      4bae »

Bromine in PDB 4bae: Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis

Enzymatic activity of Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis

All present enzymatic activity of Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis:
5.99.1.3;

Protein crystallography data

The structure of Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis, PDB code: 4bae was solved by J.A.Read, H.G.Gingell, P.Madhavapeddi, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 59.19 / 2.35
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 59.191, 78.249, 89.750, 90.00, 90.01, 90.00
R / Rfree (%) 19.42 / 23.72

Other elements in 4bae:

The structure of Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis also contains other interesting chemical elements:

Chlorine (Cl) 4 atoms
Calcium (Ca) 4 atoms

Bromine Binding Sites:

The binding sites of Bromine atom in the Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis (pdb code 4bae). This binding sites where shown within 5.0 Angstroms radius around Bromine atom.
In total 4 binding sites of Bromine where determined in the Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis, PDB code: 4bae:
Jump to Bromine binding site number: 1; 2; 3; 4;

Bromine binding site 1 out of 4 in 4bae

Go back to Bromine Binding Sites List in 4bae
Bromine binding site 1 out of 4 in the Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 1 of Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Br1256

b:71.0
occ:1.00
BR3 A:RWX1256 0.0 71.0 1.0
C4 A:RWX1256 1.9 59.3 1.0
C3 A:RWX1256 2.9 54.5 1.0
C5 A:RWX1256 3.0 54.0 1.0
N9 A:RWX1256 3.3 60.2 1.0
CL3 A:RWX1256 3.5 50.7 1.0
C7 A:RWX1256 3.6 57.0 1.0
CG2 A:VAL125 3.7 55.4 1.0
CD1 A:ILE84 3.7 68.8 1.0
CB A:ASN52 3.7 49.4 1.0
CG1 A:VAL123 3.8 69.7 1.0
CG A:ASN52 3.9 62.2 1.0
CG1 A:ILE84 4.0 66.8 1.0
N6 A:RWX1256 4.1 51.6 1.0
C17 A:RWX1256 4.1 69.3 1.0
C2 A:RWX1256 4.1 51.7 1.0
CG2 A:VAL123 4.1 72.7 1.0
OD1 A:ASN52 4.2 56.6 1.0
ND2 A:ASN52 4.3 51.4 1.0
CG1 A:VAL99 4.4 66.3 1.0
C10 A:RWX1256 4.5 64.7 1.0
O16 A:RWX1256 4.5 71.5 1.0
CB A:VAL123 4.6 71.9 1.0
C15 A:RWX1256 4.7 69.5 1.0
O8 A:RWX1256 4.8 59.4 1.0

Bromine binding site 2 out of 4 in 4bae

Go back to Bromine Binding Sites List in 4bae
Bromine binding site 2 out of 4 in the Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 2 of Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Br1255

b:65.5
occ:1.00
BR3 B:RWX1255 0.0 65.5 1.0
C4 B:RWX1255 1.9 52.9 1.0
C3 B:RWX1255 2.9 47.6 1.0
C5 B:RWX1255 3.0 48.2 1.0
CL3 B:RWX1255 3.4 43.8 1.0
N9 B:RWX1255 3.4 53.3 1.0
CD1 B:ILE84 3.6 56.8 1.0
C7 B:RWX1255 3.7 48.6 1.0
CG1 B:VAL123 3.7 57.9 1.0
CB B:ASN52 3.8 44.5 1.0
CG1 B:ILE84 3.9 57.9 1.0
CG B:ASN52 4.0 64.5 1.0
N6 B:RWX1255 4.1 48.3 1.0
C2 B:RWX1255 4.1 46.7 1.0
CG1 B:VAL125 4.2 49.0 1.0
C17 B:RWX1255 4.3 67.3 1.0
ND2 B:ASN52 4.3 46.1 1.0
OD1 B:ASN52 4.4 59.2 1.0
CG1 B:VAL99 4.4 64.4 1.0
O16 B:RWX1255 4.4 67.8 1.0
C10 B:RWX1255 4.6 58.2 1.0
CG2 B:VAL123 4.8 61.8 1.0
C15 B:RWX1255 4.8 63.3 1.0
CB B:VAL125 4.9 48.0 1.0
O8 B:RWX1255 4.9 49.3 1.0
CB B:VAL123 4.9 60.0 1.0

Bromine binding site 3 out of 4 in 4bae

Go back to Bromine Binding Sites List in 4bae
Bromine binding site 3 out of 4 in the Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 3 of Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis within 5.0Å range:
probe atom residue distance (Å) B Occ
C:Br1256

b:61.4
occ:1.00
BR3 C:RWX1256 0.0 61.4 1.0
C4 C:RWX1256 1.9 49.5 1.0
C3 C:RWX1256 2.9 44.7 1.0
C5 C:RWX1256 3.0 43.2 1.0
CL3 C:RWX1256 3.3 40.5 1.0
N9 C:RWX1256 3.4 53.4 1.0
CD1 C:ILE84 3.6 59.9 1.0
C7 C:RWX1256 3.7 48.0 1.0
C17 C:RWX1256 3.8 63.2 1.0
CB C:ASN52 3.8 40.9 1.0
CG1 C:ILE84 3.8 56.3 1.0
CG1 C:VAL123 4.0 66.3 1.0
CG C:ASN52 4.1 62.6 1.0
C2 C:RWX1256 4.1 39.2 1.0
N6 C:RWX1256 4.1 39.5 1.0
CG1 C:VAL125 4.3 48.4 1.0
O C:HOH2010 4.4 33.8 1.0
CG1 C:VAL99 4.4 65.5 1.0
CG2 C:VAL123 4.4 69.8 1.0
ND2 C:ASN52 4.4 53.4 1.0
OD1 C:ASN52 4.4 65.1 1.0
O16 C:RWX1256 4.5 63.5 1.0
C10 C:RWX1256 4.6 55.6 1.0
C15 C:RWX1256 4.7 59.6 1.0
CB C:VAL123 4.9 68.8 1.0
O8 C:RWX1256 4.9 48.9 1.0

Bromine binding site 4 out of 4 in 4bae

Go back to Bromine Binding Sites List in 4bae
Bromine binding site 4 out of 4 in the Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 4 of Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis within 5.0Å range:
probe atom residue distance (Å) B Occ
D:Br1257

b:60.4
occ:1.00
BR3 D:RWX1257 0.0 60.4 1.0
C4 D:RWX1257 1.9 44.5 1.0
C3 D:RWX1257 2.9 39.5 1.0
C5 D:RWX1257 3.0 38.8 1.0
N9 D:RWX1257 3.4 45.5 1.0
CL3 D:RWX1257 3.4 33.8 1.0
CD1 D:ILE84 3.6 50.1 1.0
C7 D:RWX1257 3.7 42.5 1.0
C17 D:RWX1257 3.7 64.6 1.0
CB D:ASN52 3.8 34.9 1.0
CG1 D:ILE84 3.8 53.8 1.0
CG D:ASN52 4.0 58.0 1.0
CG1 D:VAL123 4.1 59.0 1.0
C2 D:RWX1257 4.1 36.4 1.0
N6 D:RWX1257 4.1 34.9 1.0
O16 D:RWX1257 4.3 63.2 1.0
CG1 D:VAL99 4.4 60.3 1.0
O D:HOH2003 4.4 46.7 1.0
CG1 D:VAL125 4.4 44.8 1.0
ND2 D:ASN52 4.4 48.4 1.0
OD1 D:ASN52 4.4 50.9 1.0
CG2 D:VAL123 4.4 61.9 1.0
C10 D:RWX1257 4.6 49.6 1.0
C15 D:RWX1257 4.7 56.0 1.0
O8 D:RWX1257 4.9 44.9 1.0
CB D:VAL125 4.9 44.1 1.0
CB D:VAL123 4.9 61.4 1.0

Reference:

S.P.Hameed, S.Solapure, K.Mukherjee, V.Nandi, D.Waterson, R.Shandil, M.Balganesh, V.K.Sambandamurthy, A.K.Raichurkar, A.Deshpande, A.Ghosh, D.Awasthy, G.Shanbhag, G.Sheikh, H.Mcmiken, J.Puttur, J.Reddy, J.Werngren, J.Read, M.Kumar, M.R, M.Chinnapattu, P.Madhavapeddi, P.Manjrekar, R.Basu, S.Gaonkar, S.Sharma, S.Hoffner, V.Humnabadkar, V.Subbulakshmi, V.Panduga. Optimization of Pyrrolamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis. Antimicrob.Agents Chemother. V. 58 61 2014.
ISSN: ISSN 0066-4804
PubMed: 24126580
DOI: 10.1128/AAC.01751-13
Page generated: Wed Jul 10 20:52:05 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy